DAVID G MENTER to Protein Kinase Inhibitors
This is a "connection" page, showing publications DAVID G MENTER has written about Protein Kinase Inhibitors.
Connection Strength
0.132
-
Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6. Cancer Res. 2022 Sep 16; 82(18):3335-3344.
Score: 0.069
-
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer. Gastroenterology. 2021 07; 161(1):196-210.
Score: 0.062